• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “pandion-therapeutics” Archives

          in
          Entry Author Date Location
          Two Days, Six IPOs, and $1B Raised for Biotech Research & More Frank Vinluan 07/17/20 National
          Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More Frank Vinluan 07/17/20 National
          3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments Sarah de Crescenzo 07/13/20 National
          Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More Sarah de Crescenzo 04/03/20 National
          Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More Frank Vinluan 11/01/19 National
          Led by Gilead Veteran Riva, Glenmark’s Ichnos Steps Out on Its Own Sarah de Crescenzo 10/15/19 New York
          Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More Frank Vinluan 07/19/19 National
          Inclusion in Labs, the C-Suite & More: Xconomy Awards Diversity Finalists Frank Vinluan 08/09/18 Boston
          The 2018 Xconomy Awards Finalists Are… Corie Lok 06/28/18 Boston
          Pandion Raises $58M to Bring Cancer-Fighting Tactics to Immune Disorders Frank Vinluan 01/18/18 Boston
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • Xcelerating Life Sciences Philadelphia: The Highlights Podcast

            From Our Editors · Podcast

            Xcelerating Life Sciences Philadelphia: The Highlights Podcast

            Becoming the Cell & Gene Therapy Hub

          • What’s Next in Neuroscience Therapies

            Sponsored · Whitepaper

            What’s Next in Neuroscience Therapies

            New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

          • Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development

            Sponsored · Webinar

            Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development

            Phenotypic Screening & Profiling to Understand a Compound's Disease Impact

            Eurofins Discovery

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.